South Africa at a glance
- Population
- 64.7 million 2025
- Life expectancy at birth
- 66.3 years, 2024
- People aged 65 and over
- 6.9 % of people, 2025
- Health spending per person
- 537 US$ per person, 2023
- Doctors
- 0.79 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
South Africa Enzyme Replacement Therapy Market Industry Trends and Forecast to 2034: Segmented by (Disease, Route, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$84.3 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $75.4 Mn | — | — |
| 2025 (base) | $81.6 Mn | +$6.2 Mn | — |
| 2026 (forecast) | $88.3 Mn | +$6.7 Mn | +8.2% |
| 2027 (forecast) | $95.5 Mn | +$7.2 Mn | +17.1% |
| 2028 (forecast) | $103.4 Mn | +$7.8 Mn | +26.7% |
| 2029 (forecast) | $111.8 Mn | +$8.5 Mn | +37.1% |
| 2030 (forecast) | $121.0 Mn | +$9.2 Mn | +48.3% |
| 2031 (forecast) | $130.9 Mn | +$9.9 Mn | +60.5% |
| 2032 (forecast) | $141.7 Mn | +$10.7 Mn | +73.6% |
| 2033 (forecast) | $153.3 Mn | +$11.6 Mn | +87.9% |
| 2034 (forecast) | $165.9 Mn | +$12.6 Mn | +103.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $81.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $165.9 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Disease, route and end user (see all) |
| Key players | Sanofi, Takeda Pharmaceutical Company Ltd, BioMarin, Amicus Therapeutics, Chiesi (see all) |
| Regulator in South Africa | SAHPRASource: South African Health Products Regulatory Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Enzyme replacement therapy gives patients a missing or faulty enzyme by infusion, treating rare storage diseases such as Gaucher and Fabry.
Key segments of the enzyme Replacement Therapy market include disease (Gaucher Disease, Fabry Disease and Pompe Disease) and route (Intravenous and Subcutaneous).
Better genetic diagnosis, orphan drug incentives, patient advocacy and new gene and enzyme therapies are driving the enzyme Replacement Therapy market. More countries now have national rare disease plans.
Newborn genome screening, gene therapies and access programmes in emerging markets give the enzyme Replacement Therapy market strong growth.
Very small patient numbers, long diagnosis delays, high treatment prices and limited specialist centres hold back the enzyme Replacement Therapy market.
The enzyme Replacement Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The South African Health Products Regulatory Authority (SAHPRA) registers medicines.[1] Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone.[2]
[1] South African Health Products Regulatory Authority. Checked 14 Nov 2026.
[2] National Department of Health. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for enzyme Replacement Therapy. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in South Africa.
What doctors and scientists are doing in Enzyme Replacement Therapy right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
South Africa · 2 shared keywords
South Africa · 2 shared keywords
South Africa · 2 shared keywords
South Africa · 1 shared keyword
South Africa · 1 shared keyword
South Africa · 1 shared keyword
Medical Devices · South Africa
Healthcare Services · South Africa
Healthcare Services · South Africa
Healthcare Services · South Africa
Healthcare Services · South Africa
Healthcare Services · South Africa